1 CURRICULUM VITAE the Johns Hopkins University School Of

Total Page:16

File Type:pdf, Size:1020Kb

1 CURRICULUM VITAE the Johns Hopkins University School Of CURRICULUM VITAE The Johns Hopkins University School of Medicine Hiroshi Ashikaga, M.D., Ph.D. Date: September 30, 2018 DEMOGRAPHIC AND PERSONAL INFORMATION Current Appointments University 2018-present Associate Professor of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine (https://www.hopkinsmedicine.org/profiles/results/directory/profile/2076821/hiroshi-ashikaga) Hospital 2012-present Attending Physician, Cardiac Arrhythmia Service, Johns Hopkins Hospital Other 2018-present Visiting Scholar, IHU Liryc, Electrophysiology and Heart Modeling Institute (L'institut de rythmologie et modélisation cardiaque), Université de Bordeaux, France (https://www.ihu-liryc.fr/) Personal Data Cardiac Arrhythmia Service, Division of Cardiology, Department of Medicine Carnegie 568, 600 N. Wolfe Street Baltimore, Maryland 21287 Tel: 410-955-7534 Fax: 443-873-5019 Email: [email protected] Education and Training Undergraduate 1992 Premedical course (no degree), University of Tokyo, College of Arts and Sciences, Tokyo, Japan Doctoral/graduate 1996 M.D., University of Tokyo, Faculty of Medicine, Tokyo, Japan 2007 Ph.D., University of Tokyo, Graduate School of Medicine, Japan Thesis advisor: Ryozo Nagai, M.D. (Present position: President, Jichi Medical University, Japan) Postdoctoral 1997 Intern in Medicine, University of Tokyo Hospital, Tokyo, Japan 2000 Resident in Medicine, Beth Israel Medical Center, New York, New York 2001 Chief Resident in Medicine, Beth Israel Medical Center, New York, New York 2004 Research Fellow in Bioengineering, Division of Cardiology, University of California, San Diego Primary Mentor: James W. Covell, M.D. (Present position: Professor Emeritus, University of California, San Diego) 2006 Research Fellow in Cardiovascular MRI, Laboratory of Cardiac Energetics, National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland Primary Mentor: Elliot R. McVeigh, Ph.D. (Present position: Professor, University of California, San Diego) 2010 Clinical Fellow in Cardiovascular Disease, Johns Hopkins Hospital, Baltimore, Maryland 2012 Clinical Fellow in Clinical Cardiac Electrophysiology, Johns Hopkins Hospital, Baltimore, Maryland Professional Experience 2000-2001 Instructor of Medicine, Albert Einstein College of Medicine, Bronx, New York 2007-2008 Attending Physician, Cardiovascular Center, HIMEDIC Imaging Center, Lake Yamanaka, Japan 2007 Lecturer, Fukuoka School of Health Sciences, Japan (part-time) 2012-2018 Assistant Professor of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 2012-2017 Assistant Professor of Biomedical Engineering (secondary appointment), Department of Biomedical Engineering, Johns Hopkins University School of Medicine 1 2017-2018 Faculty, Malone Center for Engineering in Healthcare, Johns Hopkins University (https://malonecenter.jhu.edu/) 2018 Visiting Scholar, Kavli Institute of Theoretical Physics, University of California, Santa Barbara, California (https://www.kitp.ucsb.edu/) 2018-present Visiting Scholar, IHU Liryc, Electrophysiology and Heart Modeling Institute (L'institut de rythmologie et modélisation cardiaque), Université de Bordeaux, France (https://www.ihu-liryc.fr/) 2018-present Associate Professor of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland PUBLICATIONS Original Research [OR] 1. Ashikaga H, Criscione JC, Omens JH, Covell JW, Ingels NB, Jr. Transmural left ventricular mechanics underlying torsional recoil during relaxation. Am J Physiol Heart Circ Physiol. 2004;286:H640-H647. 2. Ashikaga H, Omens JH, Ingels NB, Jr, Covell JW. Transmural mechanics at left ventricular epicardial pacing site. Am J Physiol Heart Circ Physiol. 2004;286:H2401-H2407. 3. Ashikaga H, Omens JH, Covell JW. Time-dependent remodeling of transmural architecture underlying abnormal ventricular geometry in chronic volume overload heart failure. Am J Physiol Heart Circ Physiol. 2004;287:H1994- H2002. 4. Harrington KB, Rodriguez F, Cheng A, Langer F, Ashikaga H, Daughters GT, Criscione JC, Ingels NB, Jr., Miller DC. Direct measurement of transmural laminar architecture in the anterolateral wall of the ovine left ventricle: new implications for wall thickening mechanics. Am J Physiol Heart Circ Physiol. 2005;288:H1324- H1330. 5. Ashikaga H, Covell JW, Omens JH. Diastolic dysfunction in volume overload hypertrophy is associated with abnormal shearing of myolaminar sheets. Am J Physiol Heart Circ Physiol. 2005;288:H2603-H2610. 6. Ashikaga H, Mickelsen SR, Ennis DB, Rodriguez I, Kellman P, Wen H, McVeigh ER. Electromechanical analysis of infarct border zone in chronic myocardial infarction. Am J Physiol Heart Circ Physiol. 2005;289:H1099-H1105. 7. Mickelsen SR, Ashikaga H, Raval A, DeSilva R, McVeigh ER, Kusumoto FA. Transvenous access to the pericardial space: an approach to epicardial lead implantation for cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2005;28:1018-1024. 8. Moreau-Villéger V, Delingette H, Sermesant M, Ashikaga H, McVeigh ER, Ayache N. Building maps of local apparent conductivity of the epicardium with a 2-D electrophysiological model of the heart. IEEE Trans Biomed Eng. 2006;53:1457-1466. 9. Dickfeld T, Kato R, Zviman MM, Nazarian S, Dong J, Ashikaga H, Lardo AC, Berger RD, Calkins H, Halperin HR. Characterization of acute and subacute radiofrequencey ablation lesions with nonenhanced magnetic resonance imaging. Heart Rhythm. 2007;4:208-214. 10. Ashikaga H, Coppola BA, Hopenfeld B, Leifer ES, McVeigh ER, Omens JH. Transmural dispersion of myofiber mechanics: implications for electrical heterogeneity in vivo. J Am Coll Cardiol. 2007;49:909-916. 11. Hopenfeld B, Ashikaga H, McVeigh ER. Geodesic based registration of sensor data and anatomical surface image data. Ann Biomed Eng. 2007;35:1771-1781. 12. Ciaccio EJ, Ashikaga H, Kaba RA, Cervantes D, Hopenfeld B, Wit AL, Peters NS, McVeigh E, Garan H, Coromilas J. Model of reentrant ventricular tachycardia based on infarct border zone geometry predicts reentrant circuit features as determined by activation mapping. Heart Rhythm. 2007;4:1034-1045. 13. Ashikaga H, Sasano T, Dong J, Zviman MM, Evers R, Hopenfeld B, Castro V, Helm RH, Dickfeld T, Nazarian S, Donahue JK, Berger RD, Calkins H, Abraham MR, Marbán E, Lardo AC, McVeigh ER, Halperin HR. Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res. 2007;101:939-947. 14. Jöbsis PD, Ashikaga H, Wen H, Rothstein EC, Horvath KA, McVeigh ER, Balaban RS. Visceral pericardium: macromolecular structure and contribution to passive mechanical properties of the left ventricle. Am J Physiol Heart Circ Physiol. 2007;293:H3379-H3387. 15. Ashikaga H, Coppola BA, Yamazaki KG, Villarreal FJ, Omens JH, Covell JW. Changes in regional myocardial volume during the cardiac cycle: implications for transmural blood flow and cardiac structure. Am J Physiol Heart Circ Physiol. 2008;295:H610-H618. 2 16. Sasano T, Abraham MR, Chang KC, Ashikaga H, Mills KJ, Holt DP, Hilton J, Nekolla SG, Dong J, Lardo AC, Helperin H, Dannals RF, Marbán E, Bengel FM. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol. 2008;51:2266-2275. 17. Nazarian S, Kolandaivelu A, Zviman MM, Meininger GR, Kato R, Susil RC, Roguin R, Dickfeld TL, Ashikaga H, Calkins H, Berger RD, Blumke DA, Lardo AC, Halperin HR. Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies. Circulation. 2008;118:223-229. 18. Ashikaga H, van der Spoel TIG, Coppola BA, Omens JH. Transmural myocardial mechanics during isovolumic contraction. JACC Cardiovasc Imaging. 2009;2:202-211. 19. Hopenfeld B, Ashikaga H. Origin of electrocardiographic U wave: Effects of M cells and dynamic gap junction coupling. Ann Biomed Eng. 2010;38:1060-1070. 20. Ashikaga H, Leclercq C, Wang J, Kass DA, McVeigh ER. Hemodynamic improvement in cardiac resynchronization does not require improvement in left ventricular rotation mechanics: three-dimensional tagged MRI analysis. Circ Cardiovasc Img. 2010;3:456-463. 21. Estner HL, Zviman MM, Herzka D, Miller F, Castro V, Nazarian S, Ashikaga H, Dori Y, Berger RD, Calkins H, Lardo AC, Halperin HR. The critical isthmus sites of ischemic ventricular tachycardia are in zones of tissue heterogeneity, visualized by magnetic resonance imaging. Heart Rhythm. 2011;8:1942-1949. 22. Ashikaga H, Omens JH. In vivo validation of longitudinal-circumferential area change ratio to estimate myofiber shortening in the heart. IEEE Trans Biomed Eng. 2012;59:1391-1397. 23. Ashikaga H, Arevalo H, Vadakkumpadan F, Blake RC, Bayer JD, Nazarian S, Zviman MM, Tandri H, Berger RD, Calkins H, Herzka DA, Trayanova NA, Halperin HR. Feasibility of image-based simulation to estimate ablation target in human ventricular arrhythmia. Heart Rhythm. 2013;10:1109-1116. 24. Yong Ji S, Dewire J, Barcelon B, Catanzaro J, Philips B, Nazarian S, Cheng A, Spragg DD, Tandri H, Bansal S, Ashikaga H, Rickard J, Kolandaivelu A, Sinha S, Marine JE, Calkins H, Berger RD. Phrenic nerve injury: an underrecognized and potentially preventable complication of pulmonary vein isolation using a wide area circumferential ablation approach. J Cardiovasc Electrophysiol. 2013;24:1086-1091. 25. Dewire J, Agarwal S, Khurram IK, Marine JE, Berger R, Spragg D, Ashikaga H, Rickard J, Nazarian S, Calkins H. Safety and efficacy of atrial fibrillation ablation in young patients.
Recommended publications
  • Proceedings of Réanimation 2019, the French Intensive Care Society International Congress
    Ann. Intensive Care 2019, 9(Suppl 1):40 https://doi.org/10.1186/s13613-018-0474-7 MEETING ABSTRACTS Open Access Proceedings of Réanimation 2019, the French Intensive Care Society International Congress France. 23–25 January 2019 Published: 29 March 2019 Oral communications Oral communications: Physiotherapists Conclusion: We found that peak expiratory was higher with than with- out collapsible tube. In vivo measurements in patients should be done COK‑1 to confrm this fnding. Bench assessment of the efect of a collapsible tube on the efcacy of a mechanical insufation‑exsufation device Romain Lachal (speaker) Réanimation médicale, Hôpital de la Croix‑Rousse, Hospices Civils de Lyon, Lyon, FRANCE Correspondence: Romain Lachal ‑ [email protected] Annals of Intensive Care 2019, 9(Suppl 1):COK-1 Introduction: Mechanical Insufation-Exsufation (MI-E) by using a specifc device is commonly used to increase weak cough, as in patients with chronic neuromuscular weakness or in intensive care unit (ICU) patients with ICU-acquired neuro-myopathy. The assess- ment of the efcacy of MI-E device is commonly done by measuring peak cough fow (PCF). Upper airways collapse is frequently associated with neuromuscular disease and may compromise MI-E efcacy. Tra- cheomalacia is another disease that may impede PCF to increase with MI-E device. The goal of present study was to carry out a bench study to assess the efect of MI-E on PCF with and without the presence of a collapsible tube. Our hypothesis was that PCF was lower with than without collapsible tube. COK‑2 Patients and methods: We used a lung simulator (TTL Michigan Early verticalization in neurologic intensive care units Instruments) with adjustable compliance (C) and resistance (R) to with a weight suspension system which a MI-E (CoughAssist E70, Philips-Respironics) was attached, Margrit Ascher (speaker), Francisco Miron Duran, Fanny Pradalier, Claire with or without a latex collapsible tube.
    [Show full text]
  • The Future of Left Atrial Appendage Occlusions: When Extraordinary Claims Require Evidence
    Archives of Cardiovascular Disease (2015) 108, 613—616 View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Available online at ScienceDirect www.sciencedirect.com SCIENTIFIC EDITORIAL The future of left atrial appendage occlusions: When extraordinary claims require evidence. Le futur de l’exclusion de l’auricule gauche, besoin d’études pour aller plus loin a,b,∗ c Jean-Benoît Thambo , Pauline Renou a Inserm U-1045, LIRYC, institut de rythmologie et modélisation cardiaque, université de Bordeaux, Bordeaux, France b Service des cardiopathies congénitales, hôpital cardiologique du Haut-Lévêque, CHU de Bordeaux, Bordeaux, France c Unité neurovasculaire, service de neurologie, CHU de Bordeaux, Bordeaux, France Received 21 September 2015; received in revised form 29 September 2015; accepted 29 September 2015 Available online 17 November 2015 Atrial fibrillation (AF), the most common cardiac arrhythmia, is complex to manage because KEYWORDS it is associated with many other morbid conditions and complications. The most severe complication of AF is ischaemic stroke, the third most frequent cause of death and the Left atrial appendage; leading cause of serious disability worldwide. AF is one of the main causes of ischaemic Watchman; stroke, being responsible for one in five cases [1]. ACP; Owing to the incidence and severity of ischaemic stroke, its prophylaxis is a crucial Amulet; component of AF management. Stroke risk assessment scores such as the CHADS2 [2] and Anticoagulation; the CHA2DS2-VASc [3] scores have been developed to assess the risk of thromboembolic events and to determine whether a patient with AF should receive anticoagulation.
    [Show full text]
  • Restoring the Rhythm of Life
    Restoring the rhythm of life Liryc is a research, treatment, innovation and teaching institute, wholly dedicated to the study, diagnosis and treatment of cardiac electrical disorders, headed by Professor Michel Haissaguerre. These electrical disorders are responsible for various cardiovascular diseases and sudden deaths, causing directly or indirectly, around one third of all deaths in the world. At the international level, there are currently not enough research centers studying cardiac electrical activity. 90% of cardiac research centers focus on muscular contraction and mechanical or vascular functions. We are convinced that the study of this delicate electrical balance is fundamental in advancing cardiovascular pathology knowledge and in reducing the associated mortality. With the ageing of the population, the consequences of cardiac electrical dysfunction are major, both medically in terms of treatment needs and economically for society and public health spending. Understanding these complex pathologies requires a multidisciplinary approach. In regrouping a large number of national and international experts at the same center, the Liryc fully responds to these 21st century demands. Prof. Michel HAISSAGUERRE IHU Liryc Director Liryc Treatment Research Innovation Training 02.03 The heart is an electrical organ 01 OUR MISSION LIRYC, AN INSTITUTE WITH RHYTHM AT HEART The heart is a muscle stimulated by an electrical system that allows it to contract (systole) then to relax (diastole). If the heart is no longer beating, or if its rhythm is too fast or irregular, blood does not reach the different organs at all or not as much, and this can affect the whole body. Liryc’s mission is to combat and un- derstand electrical disorders of the heart.
    [Show full text]
  • L I R Y C Electrophysiology and Heart Modeling Institute
    L I R Y C Electrophysiology and Heart Modeling Institute Pr. MICHEL HAISSAGUERRE Professor of Medicine, Université Bordeaux Segalen. Head of cardiology-electrophysiology and cardiac stimulation department. Hôpital cardiologique du Haut-Lévêque - Groupe hospitalier Sud - CHU de Bordeaux. Pioneer in Cardiac Electrophysiology award 2004. Mirowski Award for Excellence in cardiology in 2009. Louis-Jeantet prize of Medicine in 2010. Member of French Académie des Sciences. Cardiovascular disease accounts for 29% of deaths in the whole world and is the leading cause of mortality ahead of infectious diseases and cancers. Half of this mortality is due to heart failure which is often secondary or aggravated by potentially reversible electrical diseases. The Implantation of the institute on the “Xavier Arnozan” site - CHU de Bordeaux other half occurs suddenly, essentially due to ventricular tachyarrhythmias similar to electrical tornados. My team has been working on the major deter- The multidisciplinary centre for minants of arrhythmic morbidity and mortality for the last 15 years. The team reported major scientific breakthroughs in atrial and ventricular translational research and innovation fibrillations, heart resynchronization, and throm- bosis with world-wide therapeutic implications. The economic, social and health burden related in cardiac electrical diseases to cardiac electrical dysfunctions will grow with the ageing European population and we believe they must receive the attention and research ef- forts commensurate with the extent and gravity of the clinical and epidemiologic burden. No country has brought together the required competencies on a single platform, despite the complexity of this pathology, which necessitates a multidisciplinary and coordinated approach. The creation of LIRYC will fully address the objec- tives of the 21st century national call to create a world-class research, clinical and teaching structure with huge innovative potential.
    [Show full text]
  • Annual Report 2018
    _Annual report 2018 Electrophysiology and heart modeling institute • A message from a founding member, Manuel Tunon de Lara _ 5 • 2018 in figures _ 6 • A message from the director, Michel Haissaguerre _ 7 • Highlights _ 8 RESEARCH • Headlines in 2018 _ 11 • Close look: advances in understanding sudden death in young people _ 12 • A look back at the publications in 2018 _ 13 INNOVATION • Headlines in 2018 _ 15 • Strategy for accelerating medical innovation _ 16 • A third liryc start-up _ 16 • A partnership in the spotlight: liryc-poietis, a scientific and technical challenge! _ 17 PATIENT CARE • Headlines in 2018 _ 19 • French leader in remote monitoring in cardiology _ 20 • Close look: the "rythm-up" trial, listening to patients _ 21 TRAINING AND EDUCATION • Headlines in 2018 _ 23 • Expanding education and training _ 24 • Close look: the alliance conference, “live cases” training for the benefit of medical innovation _ 25 MANAGEMENT • Institutional bodies _ 27 • Financial statement _ 28 _Endy Pierre, • Human ressources _ 30 Research support • Fundraising and communication _ 33 technician at Liryc • Awards and honours _ 37 • Plans for 2019 _ 38 Front cover: Nicolas Derval, Cardiologist, electrophysiology and pacing, University Hospital of Bordeaux. LIRYC: E AC THE ELECTROPHYSIOLOGY EF AND HEART MODELING PR _ INSTITUTE Liryc is a unique institute dedicated to heart rhythm disorders. These rhythm disorders are the cause of many cardiovascular diseases which account for nearly a third of deaths worldwide. Liryc is one of the six University-Hospital Institutes (IHU in French) funded by the government through its Investments for the Future Programme, with the aim of boosting _3 research and medical innovation in France.
    [Show full text]
  • L I R Y C Electrophysiology and Heart Modeling Institute
    L I R Y C Electrophysiology and Heart Modeling Institute Pr. MICHEL HAISSAGUERRE Professor of Medicine, Université Bordeaux Segalen. Head of cardiology-electrophysiology and cardiac stimulation department. Hôpital cardiologique du Haut-Lévêque - Groupe hospitalier Sud - CHU de Bordeaux. Pioneer in Cardiac Electrophysiology award 2004. Mirowski Award for Excellence in cardiology in 2009. Louis-Jeantet prize of Medicine in 2010. Member of French Académie des Sciences. Cardiovascular disease accounts for 29% of deaths in the whole world and is the leading cause of mortality ahead of infectious diseases and cancers. Half of this mortality is due to heart failure which is often secondary or aggravated by potentially reversible electrical diseases. The Implantation of the institute on the “Xavier Arnozan” site - CHU de Bordeaux other half occurs suddenly, essentially due to ventricular tachyarrhythmias similar to electrical tornados. My team has been working on the major deter- The multidisciplinary centre for minants of arrhythmic morbidity and mortality for the last 15 years. The team reported major scientific breakthroughs in atrial and ventricular translational research and innovation fibrillations, heart resynchronization, and throm- bosis with world-wide therapeutic implications. The economic, social and health burden related in cardiac electrical diseases to cardiac electrical dysfunctions will grow with the ageing European population and we believe they must receive the attention and research ef- forts commensurate with the extent and gravity of the clinical and epidemiologic burden. No country has brought together the required competencies on a single platform, despite the complexity of this pathology, which necessitates a multidisciplinary and coordinated approach. The creation of LIRYC will fully address the objec- tives of the 21st century national call to create a world-class research, clinical and teaching structure with huge innovative potential.
    [Show full text]
  • An Overview of the 6Th World Symposium on Pulmonary Hypertension
    EDITORIAL | | WORLD SYMPOSIUM ON PULMONARY HYPERTENSION An overview of the 6th World Symposium on Pulmonary Hypertension Nazzareno Galiè1, Vallerie V. McLaughlin2, Lewis J. Rubin3 and Gerald Simonneau4,5 Affiliations: 1Dept of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Bologna, Italy. 2The University of Michigan, Cardiovascular Medicine, Ann Arbor, MI, USA. 3University of California, San Diego, School of Medicine, La Jolla, CA, USA. 4Univ. Paris–Sud, AP-HP, Centre de Référence de l’Hypertension Pulmonaire Sévère, Service de Pneumologie, Département Hospitalo- Universitaire (DHU) Thorax Innovation (TORINO), Hôpital de Bicêtre, Le Kremlin Bicêtre, France. 5INSERM UMR_S999, LabEx LERMIT, Hôpital Marie Lannelongue, Le Plessis Robinson, France. Correspondence: Nazzareno Galiè, Dept of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy. E-mail: [email protected] @ERSpublications State of the art summary on diagnosis, prognosis, therapy and future perspectives of pulmonary hypertension http://ow.ly/8MHN30mGtqs Cite this article as: Galiè N, McLaughlin VV, Rubin LJ, et al. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J 2019; 53: 1802148 [https://doi.org/10.1183/13993003.02148-2018]. Since 1973 the World Symposia on Pulmonary Hypertension (WSPH) proceedings have summarised the scientific advances and future needs in this field through the efforts of multiple task forces, each focusing on a different aspect of pulmonary hypertension (PH) [1]. The 6th WSPH comprised 124 experts, divided into 13 task forces, that began their work in January 2017 and presented their consensus opinions to an audience of 1376 participant attendees between February 27 and March 1, 2018 in Nice, France.
    [Show full text]
  • The Liryc Beat
    Electrophysiology and heart modeling institute THE LIRYC BEAT NEWSLETTER N° 12 /// 1ST HALF 2021 RESEARCH & INNOVATION: RESEARCH 20 MILLION EUROS FROM EXCELLENCE TO BENEFIT EUROPE TO FOSTER CARDIAC RESEARCH EDITORIAL PATIENTS. _ page 2 As the new Chief Executive Officer of the institute, I am INNOVATION pleased to lead Liryc to address the major cardiac challenges TIC EPAC : A HOPE FOR in electrophyisiology while keeping in mind our initial goal : NEW THERAPIES, FROM bringing major advances in medical technologies to the hospital, HEART FAILURE TO ATRIAL to improve patient care. FIBRILLATION _ page 3 y concern is to pursue the strategic orientations adopted in By Pierre PATIENT CARE Mresearch, innovation, care and education, focusing on the Jaïs, DATA MANAGEMENT : Chief scientific excellence of our teams that are recognized worldwide. OPTIMIZING CARE AND Executive This appointment is an opportunity to foster Liryc’s multidisciplinary RESEARCH Officer of Liryc approach, enhancing collaborations within the institute. I feel _ page strongly about the importance of a cross-disciplinary research for 4 the enrichment of Liryc’s ecosystem to make a real difference in patient care. This is TRAINING AND EDUCATION the whole point of the European projects and international collaborations that you A NEW LIRYC-EDUCATION can read in the following pages of this newsletter. I also want to boost synergies to PLATFORM respond to the urgency of cardiac rhythm diseases. Moreover, these collaborations are _ page an opportunity for researchers to obtain grants for their ambitious projects and to be 5 published in the best scientific journals. MANAGEMENT Innovation, both in terms of practices and approaches, will allow us to adress major A NEW CEO FOR LIRYC medical issues.
    [Show full text]
  • Curriculum Vitae I
    CURRICULUM VITAE I. BIOGRAPHICAL DATA Edward Joseph Vigmond IHU Liryc Hôpital Xavier Arnozan Avenue de Haut-Levêque 33600 Pessac France [email protected] II. PROFESSIONAL RECORD A. Academic Record i) Undergraduate B.A.Sc., 04/1988 Electrical and Computer Engineering University of Toronto/Toronto/Canada ii) Graduate M.A.Sc., 04/1991 Electrical and Computer Engineering, Institute of Biomedical Engineering University of Toronto/Toronto/Canada Ph.D., 01/1997 Electrical and Computer Engineering, Institute of Biomedical Engineering University of Toronto/Toronto/Canada Diplôme d’habilitation à Diriger Des Recherches, 01, 2017 University of Bordeaux/Bordeaux/France iii) Post-doctoral or other special training • Postdoctoral Fellow, 06/1997–07/1999 Biomedical Engineering Institut de génie biomédical/Université de Montréal/Montreal/Canada Supervisor: Dr. L. Josh Leon • Postdoctoral Fellow, 08/1999–06/2001 Biomedical Engineering Department of Biomedical Engineering,Tulane University/New Orleans/U.S.A Supervisor: Dr. Natalia A. Trayanova B. Academic and Other Appointments • Researcher, L’Institut Rythmologie et Modelisation Cardiaque (Liryc), Université de Bor- deaux, 1/2012–present • Associate Professor, University of Calgary, 07/2005–11/2011 E. Vigmond CV: Graduate Level Instruction 2 • Assistant Professor, University of Calgary, 07/2001–06/2005 C. Administrative Responsibilities • Head of Modelling Team, LIRYC Institute, 1/2012–present • Associate Director for the Biomedical Engineering Undergraduate Specialization, 01/2008– 8/2009 • Director, Center for BioEngineering Research and Education, 01/2009–11/2011 D. Professional Certification and Memberships in Learned Societies • Professional Engineer, APEGGA, January 2003–Nov 2011 • Member, IEEE Engineering in Medicine and Biology, 1998–present • Member, Libin Cardiovascular Institute, University of Calgary, 2005–present.
    [Show full text]